These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10497157)

  • 41. A functional role of the C-terminal 42 amino acids of SUR2A and SUR2B in the physiology and pharmacology of cardiovascular ATP-sensitive K(+) channels.
    Yamada M; Kurachi Y
    J Mol Cell Cardiol; 2005 Jul; 39(1):1-6. PubMed ID: 15978900
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SUR2 subtype (A and B)-dependent differential activation of the cloned ATP-sensitive K+ channels by pinacidil and nicorandil.
    Shindo T; Yamada M; Isomoto S; Horio Y; Kurachi Y
    Br J Pharmacol; 1998 Jul; 124(5):985-91. PubMed ID: 9692785
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mg2+ and ATP dependence of K(ATP) channel modulator binding to the recombinant sulphonylurea receptor, SUR2B.
    Hambrock A; Löffler-Walz C; Kurachi Y; Quast U
    Br J Pharmacol; 1998 Oct; 125(3):577-83. PubMed ID: 9806343
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A transmembrane domain of the sulfonylurea receptor mediates activation of ATP-sensitive K(+) channels by K(+) channel openers.
    D'hahan N; Jacquet H; Moreau C; Catty P; Vivaudou M
    Mol Pharmacol; 1999 Aug; 56(2):308-15. PubMed ID: 10419549
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The tolbutamide site of SUR1 and a mechanism for its functional coupling to K(ATP) channel closure.
    Babenko AP; Gonzalez G; Bryan J
    FEBS Lett; 1999 Oct; 459(3):367-76. PubMed ID: 10526167
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Two regions of sulfonylurea receptor specify the spontaneous bursting and ATP inhibition of KATP channel isoforms.
    Babenko AP; Gonzalez G; Bryan J
    J Biol Chem; 1999 Apr; 274(17):11587-92. PubMed ID: 10206966
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Unresponsiveness to glibenclamide during chronic treatment induced by reduction of ATP-sensitive K+ channel activity.
    Kawaki J; Nagashima K; Tanaka J; Miki T; Miyazaki M; Gonoi T; Mitsuhashi N; Nakajima N; Iwanaga T; Yano H; Seino S
    Diabetes; 1999 Oct; 48(10):2001-6. PubMed ID: 10512365
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An amino acid triplet in the NH2 terminus of rat ROMK1 determines interaction with SUR2B.
    Dong K; Xu J; Vanoye CG; Welch R; MacGregor GG; Giebisch G; Hebert SC
    J Biol Chem; 2001 Nov; 276(47):44347-53. PubMed ID: 11567030
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Substitution of the Walker A lysine by arginine in the nucleotide-binding domains of sulphonylurea receptor SUR2B: effects on ligand binding and channel activity.
    Amann T; Schell S; Kühner P; Winkler M; Schwanstecher M; Russ U; Quast U
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Jun; 381(6):507-16. PubMed ID: 20352196
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rat homolog of sulfonylurea receptor 2B determines glibenclamide sensitivity of ROMK2 in Xenopus laevis oocyte.
    Tanemoto M; Vanoye CG; Dong K; Welch R; Abe T; Hebert SC; Xu JZ
    Am J Physiol Renal Physiol; 2000 Apr; 278(4):F659-66. PubMed ID: 10751228
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Electrophysiological and pharmacological characterization of the K(ATP) channel involved in the K+-current responses to FSH and adenosine in the follicular cells of Xenopus oocyte.
    Fujita R; Kimura S; Kawasaki S; Watanabe S; Watanabe N; Hirano H; Matsumoto M; Sasaki K
    J Physiol Sci; 2007 Feb; 57(1):51-61. PubMed ID: 17239259
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sulfonylurea stimulation of insulin secretion.
    Proks P; Reimann F; Green N; Gribble F; Ashcroft F
    Diabetes; 2002 Dec; 51 Suppl 3():S368-76. PubMed ID: 12475777
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Functional involvement of sulphonylurea receptor (SUR) type 1 and 2B in the activity of pig urethral ATP-sensitive K+ channels.
    Yunoki T; Teramoto N; Ito Y
    Br J Pharmacol; 2003 Jun; 139(3):652-60. PubMed ID: 12788825
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modulation of the trafficking efficiency and functional properties of ATP-sensitive potassium channels through a single amino acid in the sulfonylurea receptor.
    Cartier EA; Shen S; Shyng SL
    J Biol Chem; 2003 Feb; 278(9):7081-90. PubMed ID: 12496311
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The size of a single residue of the sulfonylurea receptor dictates the effectiveness of K ATP channel openers.
    Moreau C; Gally F; Jacquet-Bouix H; Vivaudou M
    Mol Pharmacol; 2005 Apr; 67(4):1026-33. PubMed ID: 15615694
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antisense oligodeoxynucleotides of sulfonylurea receptors inhibit ATP-sensitive K+ channels in cultured neonatal rat ventricular cells.
    Yokoshiki H; Sunagawa M; Seki T; Sperelakis N
    Pflugers Arch; 1999 Feb; 437(3):400-8. PubMed ID: 9914396
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The actions of a novel potent islet beta-cell specific ATP-sensitive K+ channel opener can be modulated by syntaxin-1A acting on sulfonylurea receptor 1.
    Ng B; Kang Y; Elias CL; He Y; Xie H; Hansen JB; Wahl P; Gaisano HY
    Diabetes; 2007 Aug; 56(8):2124-34. PubMed ID: 17496234
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sulfonylurea and K(+)-channel opener sensitivity of K(ATP) channels. Functional coupling of Kir6.2 and SUR1 subunits.
    Koster JC; Sha Q; Nichols CG
    J Gen Physiol; 1999 Aug; 114(2):203-13. PubMed ID: 10435998
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cooperative binding of ATP and MgADP in the sulfonylurea receptor is modulated by glibenclamide.
    Ueda K; Komine J; Matsuo M; Seino S; Amachi T
    Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1268-72. PubMed ID: 9990013
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Ontogeny of sulphonylurea-binding regulatory subunits of K(ATP) channels in the pregnant rat myometrium].
    Lovász N; Ducza E; Gáspár R; Falkay G
    Acta Pharm Hung; 2011; 81(3):101-7. PubMed ID: 22165413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.